Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

Treating nicotine addiction with glucagon-like peptide 1 receptor agonists is associated with less weight gain compared with ...

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of ...

Pepsi's slump is mainly due to aggressive price hikes and high T-bond yields, not diworsification or health trends.

In recent years, Kessler has lost considerable weight himself with the help of the new GLP-1 drugs. He describes his weight ...

Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

And since GLP-1s come with side effects including fatigue, digestive difficulties, and loss of muscle, products to address ...

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

The popularity of GLP-1 drugs has insurance companies scrambling to satisfy consumer access while reining in exorbitant costs ...

Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...